Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Massachusetts will stop covering GLP-1 weight-loss drugs for public workers and retirees in July to save $100–120 million, keeping coverage for diabetes.
The Massachusetts Group Insurance Commission voted 10-7 to stop covering GLP-1 drugs for weight loss for public employees and retirees, effective July, citing budget pressures and a need to save $100–120 million.
The move affects about 22,000 members using the drugs for obesity, though coverage remains for diabetes treatment.
The decision aligns with commercial insurers and aims to reduce premiums, with officials hoping it will pressure drugmakers to lower prices.
Critics warn it may worsen health inequities and set a precedent for cutting other benefits, while the GIC expects a $300 million state infusion to cover claims.
Massachusetts dejará de cubrir los medicamentos para la pérdida de peso GLP-1 para los trabajadores públicos y jubilados en julio para ahorrar $ 100-120 millones, manteniendo la cobertura para la diabetes.